Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Monocyte proinflammatory phenotypic control by ephrin type A receptor 4 mediates neural tissue damage
Elizabeth A. Kowalski, Eman Soliman, Colin Kelly, Erwin Kristobal Gudenschwager Basso, John Leonard, Kevin J. Pridham, Jing Ju, Alison Cash, Amanda Hazy, Caroline de Jager, Alexandra M. Kaloss, Hanzhang Ding, Raymundo D. Hernandez, Gabe Coleman, Xia Wang, Michelle L. Olsen, Alicia M. Pickrell, Michelle H. Theus
Elizabeth A. Kowalski, Eman Soliman, Colin Kelly, Erwin Kristobal Gudenschwager Basso, John Leonard, Kevin J. Pridham, Jing Ju, Alison Cash, Amanda Hazy, Caroline de Jager, Alexandra M. Kaloss, Hanzhang Ding, Raymundo D. Hernandez, Gabe Coleman, Xia Wang, Michelle L. Olsen, Alicia M. Pickrell, Michelle H. Theus
View: Text | PDF
Research Article Neuroscience

Monocyte proinflammatory phenotypic control by ephrin type A receptor 4 mediates neural tissue damage

  • Text
  • PDF
Abstract

Circulating monocytes have emerged as key regulators of the neuroinflammatory milieu in a number of neuropathological disorders. Ephrin type A receptor 4 (Epha4) receptor tyrosine kinase, a prominent axon guidance molecule, has recently been implicated in the regulation of neuroinflammation. Using a mouse model of brain injury and a GFP BM chimeric approach, we found neuroprotection and a lack of significant motor deficits marked by reduced monocyte/macrophage cortical infiltration and an increased number of arginase-1+ cells in the absence of BM-derived Epha4. This was accompanied by a shift in monocyte gene profile from pro- to antiinflammatory that included increased Tek (Tie2 receptor) expression. Inhibition of Tie2 attenuated enhanced expression of M2-like genes in cultured Epha4-null monocytes/macrophages. In Epha4-BM–deficient mice, cortical-isolated GFP+ monocytes/macrophages displayed a phenotypic shift from a classical to an intermediate subtype, which displayed reduced Ly6chi concomitant with increased Ly6clo- and Tie2-expressing populations. Furthermore, clodronate liposome–mediated monocyte depletion mimicked these effects in WT mice but resulted in attenuation of phenotype in Epha4-BM–deficient mice. This demonstrates that monocyte polarization not overall recruitment dictates neural tissue damage. Thus, coordination of monocyte proinflammatory phenotypic state by Epha4 is a key regulatory step mediating brain injury.

Authors

Elizabeth A. Kowalski, Eman Soliman, Colin Kelly, Erwin Kristobal Gudenschwager Basso, John Leonard, Kevin J. Pridham, Jing Ju, Alison Cash, Amanda Hazy, Caroline de Jager, Alexandra M. Kaloss, Hanzhang Ding, Raymundo D. Hernandez, Gabe Coleman, Xia Wang, Michelle L. Olsen, Alicia M. Pickrell, Michelle H. Theus

×

Figure 4

Monocyte depletion and loss of Epha4 alters tissue damage, peripheral monocyte influx, and phenotype after brain injury.

Options: View larger image (or click on image) Download as PowerPoint
Monocyte depletion and loss of Epha4 alters tissue damage, peripheral mo...
(A–D) Representative images of the ipsilateral cortices of Nissl-stained coronal sections from (A) liposome control–treated +WTBMC (nondepleted), (B) liposome control–treated +KOBMC (nondepleted), (C) clodronate-treated +WTBMC (monocyte depletion), and (D) clodronate-treated +KOBMC (monocyte depletion) mice at 3 dpi. Tile image magnification x4. (E) Lesion volume (mm3) at 3 dpi was estimated in 5 Nissl-stained serial coronal sections using the Cavalieri Estimator. (F–N) Flow cytometry analysis was used to examine the differential abundance of peripheral GFP+ immune cell populations infiltrating the ipsilateral cortices of liposome control–treated +WTBMC, liposome control–treated +KOBMC, clodronate-treated +WTBMC, and clodronate-treated +KOBMC mice. Using FACS, we found the percentage of peripherally derived (F) GFP+CD11b+ cells, (G) monocytes (GFP+CD11b+Ly6g–), (H) neutrophils (GFP+CD11b+Ly6g+), (I) classical monocytes (GFP+CD11b+Ly6g–Cx3cr1–Ccr2+), (J) intermediate monocytes (GFP+CD11b+Ly6g–Cx3cr1+Ccr2+), and (K) nonclassical monocytes (GFP+CD11b+Ly6g–Ccr2–Cx3cr1+). FACS also showed changes in (L) intermediate Ly6chi (GFP+CD11b+Ly6g–Cx3cr1+Ccr2+Ly6chi) and (M) Ly6clo (GFP+CD11b+Ly6g–Cx3cr1+Ccr2+Ly6clo) monocytes. (N) Epha4 mean fluorescence intensity on intermediate monocytes (GFP+CD11b+Ly6g–Cx3cr1+Ccr2+Epha4) from control- and clodronate-treated +WTBMC mice is reduced in depleted WT mice. Statistical analysis was performed using 1-way ANOVA with multiple comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. n = 6–8 mice per group. Combined data are from multiple independent experiments. Ctx, cortex; hippo, hippocampus; Dep, depleted.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts